Tesla insider files Form 144 to sell 2,606 restricted shares on NASDAQ
Rhea-AI Filing Summary
Form 144 filed for TSLA insider sale of restricted shares. The notice reports an intended sale of 2,606 shares of common stock through Morgan Stanley Smith Barney on or about 09/08/2025 on NASDAQ, with an aggregate market value of $918,311.40. The shares were acquired as restricted stock on 09/05/2025 and paid for on that date. The filing also lists three prior sales by the same person in the past three months: 2,000, 4,000, and 2,564 shares with gross proceeds of $600,000.00, $1,171,544.40, and $732,571.93, respectively. The filer attests there is no undisclosed material adverse information.
Positive
- Required disclosures provided: broker, share counts, acquisition date, and past three months' sales are all listed
- Insider attestation that no undisclosed material adverse information exists
Negative
- Insider sales activity: three prior sales in the past three months totaling 8,564 shares (documented proceeds)
- Rapid disposition of restricted shares acquired on 09/05/2025 with planned sale on 09/08/2025
Insights
TL;DR: Insider intends to sell newly issued restricted shares; recent months show multiple sizable dispositions.
The filing documents a proposed sale of 2,606 restricted shares valued at $918,311.40 to be executed through Morgan Stanley Smith Barney on NASDAQ around 09/08/2025. The acquisition and planned sale occur within days of each other, indicating disposition of newly vested or granted restricted stock. The filing also discloses three prior sales in the past three months totaling 8,564 shares with stated gross proceeds on each trade. This is a routine Rule 144 disclosure that provides transparency on an insider's sales activity but contains no earnings or operational data.
TL;DR: Form 144 appears complete for the proposed transaction and includes required recent-sales disclosures.
The notice includes required fields: broker name and address, share counts, market value, acquisition date and nature (restricted stock), and past three months of sales with gross proceeds. The signer affirms no undisclosed material adverse information and acknowledges legal liability for misstatements. The filing does not show a trading-plan date or 10b5-1 adoption, and none is asserted in the remarks.